10x Genomics (TXG) Non Operating Income (2018 - 2026)

10x Genomics has disclosed Non Operating Income across 9 years of filings, most recently posting $910000.0 for Q2 2026.

• In Q2 2026, Non Operating Income fell 86.76% year-over-year to $910000.0; the TTM figure through Jun 2026 stood at $13.5 million (down 36.35% YoY), while the FY2025 annual figure was $21.1 million, up 25.03% from the prior year.
• Non Operating Income came in at $910000.0 for Q2 2026 at 10x Genomics, down from $4.2 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $8.6 million in Q4 2023 to a low of -$714000.0 in Q2 2022.
• Average Non Operating Income over 5 years is $3.6 million, with a median of $3.9 million recorded in 2024.
• Year-over-year, Non Operating Income tumbled 292.97% in 2022 and jumped 7923.08% in 2023.
• Over 5 years, Non Operating Income stood at $6.7 million in 2022, then climbed by 28.5% to $8.6 million in 2023, then sank by 83.02% to $1.5 million in 2024, then jumped by 198.01% to $4.3 million in 2025, then slumped by 79.07% to $910000.0 in 2026.
• Per Business Quant data, the three most recent Non Operating Income figures were $910000.0 in Q2 2026, $4.2 million in Q1 2026, and $4.3 million in Q4 2025.